| Term 
 | Definition 
 
        | 1st generation H1 antagonist; allergy relief; sleep aid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd generation H1 antagonist; allergy relief |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd generation H1 antagonist; allergy relief |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd generation H1 antagonist; allergy relief |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd generation H1 antagonist; allergy relief |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd generation H1 antagonist; allergy relief |  | 
        |  | 
        
        | Term 
 
        | H1 antagonists (1 first gen, 5 second gen) |  | Definition 
 
        | 1st gen: diphenhydramine (CNS side effects). 2nd gen: fexofenADINE, loratADINE, desloratADINE, levocetirizine, azelastin.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | H2 antagonist; reduce gastric acid; INHIBITS P450 SYSTEM |  | 
        |  | 
        
        | Term 
 
        | Which H2 antagonist inhibits the P450 system? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | H2 antagonist; reduce gastric acid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | H2 antagonist; reduce gastric acid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | H2 antagonist; reduce gastric acid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CimetIDINE, ranitIDINE, nizatIDINE, famotIDINE |  | 
        |  | 
        
        | Term 
 
        | Which H1 antagonist has CNS side effects? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; bronchodilator; short-acting beta-2 agonist (SABA) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; bronchodilator; short-acting beta-2 agonist (SABA) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; bronchodilator; LONG-acting beta-2 agonist (LABA) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; bronchodilator; xanthine; oral or IV (aminophylline); rarely used |  | 
        |  | 
        
        | Term 
 
        | Beta-2 agonists for asthma (3) |  | Definition 
 
        | Albuterol, salmeterol, terbutaline ("ASThma") |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; inhaled corticosteroid (ICS); HIGH potency |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; inhaled corticosteroid (ICS); HIGH potency |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; inhaled corticosteroid (ICS); LOW potency |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; inhaled corticosteroid (ICS); LOW potency |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Inhaled corticosteroids (2 high potency, 2 low potency) |  | Definition 
 
        | High: FLUticaSONE, [B]udesonIDE. Low: FLUnisolIDE, [B]eclomethaSONE.
 "[B]ird FLU." "ONE is like prednisONE"
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; anti-inflammatory; prophylactic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; anti-inflammatory; asthma prophylactic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bronchodilator; muscarinic antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; bronchodilator + anti-inflam.; CysLTR1 antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; bronchodilator + anti-inflam.; CysLTR1 antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; bronchodilator + anti-inflam., 5-lipoxygenase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma; anti-inflam.; anti-IgE antibodies |  | 
        |  | 
        
        | Term 
 
        | Anti-leukotrienes (2 receptor antagonists [LTRA's], 1 5-lipoxygenase inhibitor) |  | Definition 
 
        | LTRA's: MonteLUKAST, ZafirLUKAST 5-LO inhibitor: zileuton
 |  | 
        |  | 
        
        | Term 
 
        | Acetylsalicylic acid (aspirin) |  | Definition 
 
        | Antiplatelet; irreversible COX inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiplatelet agent; metabolite = ADP receptor irreversible antagonist (platelet surface) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiplatelet; 1st GPIIb/IIIa receptor antagonist; MOST POTENT; IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiplatelet; SYNTHETIC PGI2; IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-platelet; PDE3 inhibitor (keeps cAMP alive); used for intermittent claudication |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hemostatic; plasminogen inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hemostatic; heparin inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-coagulant; RAPID via IV (hard to control) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-coagulant; oral; slower than heparin but has adverse drawbacks; metabolized by P450 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-coagulant; LMWH (therefore, easier dosing).  "rin" = heparin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-coagulant; factor Xa inhibitor.  "F_____x = [F]ondaparinu[X]; [F]actor [X]" |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Thrombolytic ("clot buster"); recombinant tPA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Thrombolytic ("clot buster"); alternative to tPA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Thrombolytic ("clot buster"); alternative to tPA |  | 
        |  | 
        
        | Term 
 
        | Antiplatelets (3 oral, 2 IV) |  | Definition 
 
        | Oral: Aspirin, clopidogrel, cilostazol. IV: Abciximab, epoprostenol (PGI2)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tranexamic acid, protamine sulphate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | HepARIN, warfARIN, enoxApRIN, fondapARINux ("ARIN = without fibrin")
 |  | 
        |  | 
        
        | Term 
 
        | Thrombolytics ("clot busters") (3) |  | Definition 
 
        | AlteplASE (tPA), streptoKINASE, uroKINASE |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; reduces cholesterol absorption |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; statin = HMG CoA reductase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; statin = HMG CoA reductase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; statin = HMG CoA reductase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; statin = HMG CoA reductase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; statin = HMG CoA reductase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; statin = HMG CoA reductase inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; bile acid resin (USMLE artifact) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; bile acid resin (USMLE artifact) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; ONLY bile acid resin that anyone uses; ↓LDL |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; fibrate = PPAR-α agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; fibrate = PPAR-α agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; vitamin mega-dose; ↑↑HDL |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; vitamin mega-dose |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agents; still in trials; blocks transfer of cholesterol esters/TGs between lipoproteins |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; blocks cholesterol transporter in intestine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lipid lowering agent; drug combo; statin (endogenous) + cholesterol transporter inhibitor (exogenous) |  | 
        |  | 
        
        | Term 
 
        | Statins (good effects/side effects) |  | Definition 
 
        | Good = ↓↓LDL, ↓TGs.  Potential side effects = teratogenic, liver dz, myopathy (soreness to rhabdomyolysis), minor GI sx (cramps, constipation) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Best = COLEsevelam.  Unimportant = CHOLEstyramine, COLEstipol |  | 
        |  | 
        
        | Term 
 
        | Fibrates (2) (good effects) |  | Definition 
 
        | GemFIBRozil, fenoFIBRATE.  PPAR-α agonist = ↓↓VLDL, ↑HDL |  | 
        |  | 
        
        | Term 
 
        | Glyceryl trinitrate (nitroglycerin) |  | Definition 
 
        | Anti-anginal; vasodilator; organic nitrate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-anginal; vasodilator; organic nitrate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-anginal; vasodilator; organic nitrate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-anginal; Class IV Antiarrhythmic; VOCC antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-anginal; Class II Antiarrhythmic; nonspecific β-blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-anginal; inhibits fatty acid oxidation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-anginal; Class II Antiarrhythmic; β1-antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Glyceryl trinitrate; isosorbide dinitrate; isosorbide mononitrate.  VENOdilators |  | 
        |  | 
        
        | Term 
 
        | Sympatholytics for angina (2) |  | Definition 
 
        | Propanolol (nonspecific) and atenolol (β1-antagonist) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; vasodilator; ACE inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; vasodilator; ACE inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; vasodilator; ACE inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; vasodilator; Angiotensin Receptor Blocker (ARB) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; vasodilator (POTENT); IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; vasodilator; acts directly on ARTERIOLES; never use alone! |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; vasodilator AND diuretic; only use for ACUTE HF with dyspnea at rest |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; diuretic; oral or IV |  | 
        |  | 
        
        | Term 
 
        | Hydrochlorothiazide (HCTZ) |  | Definition 
 
        | Heart failure; diuretic; thiazide |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; diuretic; aldosterone antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; diuretic; aldosterone antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; sympatholytic; Antiarrhythmic; β1-blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; sympatholytic; β1-blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; sympatholytic; combined α/β blocker |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; inotrope; antiarrhythmic (AV block); inhibits Na/K channels; oral/IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympathomimetic; big increase in contractility with small increase in HR; IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sympathomimetic (mostly dopaminergic but also β-agonist); IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heart failure; phosphodiesterase inhibitor; IV |  | 
        |  | 
        
        | Term 
 
        | RAAS inhibitors (3 ACE inhibitors, 1 ARB) |  | Definition 
 
        | ACE inhibitors: captoPRIL, enalaPRIL, lisinoPRIL. ARB: Losartan
 |  | 
        |  | 
        
        | Term 
 
        | Vasodilators for heart failure (3 ACE inhibitors, 1 ARB, 3 misc) |  | Definition 
 
        | ACE inhibitors (warning: potassium-sparing!): CaptoPRIL, enalaPRIL, lisinoPRIL.  ACE inhibitors = ARTERIAL dilators. ARB (not potassium-sparing): Losartan.
 Others: Na Nitroprusside, hydralazine, nesiritide (doubles as diuretic).
 |  | 
        |  | 
        
        | Term 
 
        | Diuretics for heart failure (2 aldosterone antagonists, 3 misc) |  | Definition 
 
        | Aldosterone antagonists: SpironolactONE, eplerenONE (warning: potassium-sparing!). ("keeps you from going 'number one'") Misc: NesiritIDE (doubles as vasodilator), furosemIDE, hydrochlorothiazIDE |  | 
        |  | 
        
        | Term 
 
        | Sympathomimetics for heart failure (2) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class Ia antiarrhythmic.  Good for a.fib./v.fib. COMBO due to multiple effects. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class Ib antiarrhythmic.  Great for v.fib. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class II antiarrhythmic.  Great for a.fib. and AV nodal re-entry. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class II antiarrhythmic.  Great for a.fib. and AV nodal re-entry. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class III antiarrhythmic.  Serious side effects = pulmonary fibrosis, liver toxicity, thyroid abnormalities. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class III antiarrhythmic.  Fewer side effects than amiodarone, but weaker. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class III antiarrhythmic.  Fewer side effects than amiodarone, but weaker. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antianginal; VOCC antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antianginal; Class IV antiarrhythmic; VOCC antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiarrhythmic; diagnostic |  | 
        |  | 
        
        | Term 
 
        | What are the four main targets of antiarrhythmic drugs? |  | Definition 
 
        | Class I = sodium channels.  Class II = β-activation.  Class III = potassium channels.  Class IV = calcium channels. ("NBKC") |  | 
        |  | 
        
        | Term 
 
        | Which antiarrhythmic classes are supraventricular?  Ventricular? |  | Definition 
 
        | Supraventricular = II and IV.  Ventricular = I and III.  ("Even Stephen" = even numbers for Supra) |  | 
        |  | 
        
        | Term 
 
        | What are the PRIMARY drugs to remember for each class of antiarrhythmic? |  | Definition 
 
        | Class I = lidocaine.  II = propanolol.  III = sotalol, bretylium, amiodarone.  IV = verapamil. ("3 for 3") |  | 
        |  | 
        
        | Term 
 
        | What do organic nitrates dilate: arteries or veins? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | The first (and worst) statin.  80-fold increase in rhabdomyolysis. |  | 
        |  | 
        
        | Term 
 
        | ACE Inhibitors: Contraindications/undesirable effects (hint: CAPTOPRIL) |  | Definition 
 
        | Cough, Angioedema, Proteinuria, Taste changes, hypOtension, Pregnancy, Rash, Increased renin, Lower AngII (and thus, hyperkalemia) |  | 
        |  |